Myelopathy Because of CAR-T-Related Neurotoxicity Treated With Siltuximab

Siltuximab may be effective in patients with severe neurotoxicity after chimeric antigen receptor T-cell (CAR-T) therapy by lowering CNS interleukin-6 levels.

Source: Neurology Clinical Practice - December 13, 2021 Category: Neurology Authors: Aghajan, Y., Yu, A., Jacobson, C. A., Kim, A. I., Kean, L., Robertson, M., Vaitkevicius, H. Tags: All Oncology, All Spinal Cord, Critical care Case Source Type: research